Side Effects of Aubagio

Article Plan⁚ Side Effects of Aubagio

Introduction

The medication Aubagio, also known as teriflunomide, is used in the treatment of relapsing forms of multiple sclerosis (MS).​ Like many medications, Aubagio can potentially lead to a range of side effects, some of which may be common while others could be serious.​ Understanding these side effects is essential for both patients and healthcare providers to ensure the safe use of this medication.

Common Side Effects

Common side effects of Aubagio (teriflunomide) may include increased levels of liver enzymes signaling liver disease, hair thinning or loss, diarrhea, influenza, nausea, low phosphate levels, and numbness or a burning sensation in legs, hands, arms, or feet. It is important to note that some of these side effects may improve as the body adjusts to the medication.​ If you continue to experience these symptoms or if they worsen over time, it is crucial to notify your healthcare provider promptly.​

Serious Side Effects

Some serious side effects of Aubagio (teriflunomide) may include hives, difficulty breathing, swelling of the face, lips, tongue, or throat, fever, sore throat, skin pain, red or purple skin rash with blistering and peeling, and numbness or tingling in the hands or feet that feels different from typical MS symptoms. It is essential to seek immediate medical attention if you experience any of these severe side effects while taking Aubagio.​

Risk Factors

When taking Aubagio (teriflunomide), there are certain risk factors to be aware of.​ The medication can potentially increase the risk of liver problems, and individuals with pre-existing liver conditions or those taking other medications that affect the liver may have a higher risk of experiencing liver-related side effects.​ Additionally, if an individual suspects an overdose of Aubagio, it is crucial to seek guidance from a healthcare provider or Poison Control immediately.​ In cases of severe toxicity, specific treatments may be required to eliminate the medication from the body.​

Management of Side Effects

It is important to manage the side effects of Aubagio (teriflunomide) effectively to ensure the well-being of individuals using this medication.​ Strategies for managing common side effects, such as increased liver enzymes, hair thinning, diarrhea, and numbness, may involve close monitoring by healthcare providers, adjusting the dosage if necessary, providing supportive care to alleviate symptoms, and considering alternative treatment options if side effects persist or become severe.​ Patients should communicate any side effects they experience to their healthcare team promptly to receive appropriate guidance and support.​

Long-term Effects

The long-term effects of Aubagio (teriflunomide) are a significant consideration for individuals undergoing treatment for multiple sclerosis.​ Prolonged use of Aubagio may lead to potential liver problems and the risk of adverse reactions associated with liver function. Close monitoring of liver enzymes and overall liver health is crucial for individuals on long-term Aubagio therapy to minimize any long-term negative impacts on liver function.​ Additionally, continued communication with healthcare providers regarding any persistent or worsening side effects is essential for long-term management of overall health while using Aubagio.

In conclusion, understanding the potential side effects of Aubagio (teriflunomide) is crucial for patients and healthcare providers to ensure the safe and effective management of multiple sclerosis.​ While common side effects such as liver enzyme elevations, hair thinning, and gastrointestinal symptoms may be manageable, it is essential to be vigilant of serious side effects like liver problems and severe skin reactions.​ Monitoring for long-term effects on liver health and promptly addressing any concerning symptoms are paramount in the holistic care of individuals undergoing Aubagio treatment.​ Effective communication between patients and healthcare providers is essential for navigating potential side effects and optimizing the safety and efficacy of Aubagio therapy.